期刊文献+

生物影像研究进展及问题 被引量:1

原文传递
导出
摘要 自1895年伦琴发现X射线以来,放射影像对疾病诊断与指导治疗一直起着非常重要作用。随着正电子发射断层显像(positron emission tomography,PET)和单光子发射计算机断层显像(single photon emission computed tomography,SPECT)的研制成功,使放射影像从传统的解剖结构影像进入了生物影像阶段。
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2009年第6期501-503,共3页 Chinese Journal of Radiation Oncology
  • 相关文献

参考文献28

  • 1Van Den Bossche B, Van de Wiele C. Receptor imaging in oneology by means of nuclear medicine: current status. J Clin Oncol, 2004,22:3593-3607.
  • 2Apisarnthanarax S, Chao KS. Current imaging paradigms in radiation oncology. Radiat Res,2005,163 : 1-25.
  • 3王荣福.肿瘤影像核医学进展[J].中国医学影像技术,2004,20(11):1792-1796. 被引量:16
  • 4Heron DE, Smith RP, Andrade RS. Advances in image-guided radiation therapy-the role of PET-CT. Med Dosim,2006,31:3-11.
  • 5Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med,2001,42(5 Suppl) : 1- 93.
  • 6De Oei GLF, van der Heijden HF, Corstens FH, et al. Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review. Cancer,2007,110 : 1654-1664.
  • 7Wang D, Schuhz C J, Jursinic PA, et al. Initial experience of FDGPET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys,2006,65 : 143-151.
  • 8Schoder H, Gonen M. Screening for cancer with PET and PET/ CT: potential and limitations. J Nucl Med,2007,48 Suppl 1:4- 18.
  • 9Torigian DA, Huang SS, Houseni M, et al. Functional Imaging of Cancer with Emphasis on Molecular Techniques. CA Cancer J Clin, 2007,57:206 -224.
  • 10王冕荣,杨伟志.肿瘤乏氧问题的研究进展[J].中华放射肿瘤学杂志,2004,13(4):343-346. 被引量:1

二级参考文献56

  • 1王荣福,张春丽.Clinical application of radioimmunoi maging with (99)~m Tc-BDI-1in the diagnosis of bladder cancer[J].Chinese Medical Journal,2000(5):12-15. 被引量:5
  • 2王荣福.放射性正电子药物在肿瘤中的应用研究[J].实用肿瘤杂志,2006,21(1):92-95. 被引量:13
  • 3范岩 张春丽 付占立 等.^99Tc^m—HL91在荷瘤小鼠体内的分布特点及与^18F—FDG和^99Tc^m—MIBI的对比[J].北京大学学报:医学版,2001,33:16-16.
  • 4Yutani K, Kusuoka H, Fukuchi K, et al. Applicability of ^99Tc^m-HL91, a putative hypoxic tracer, to detection of tumor hypoxia[J]. J Nucl Med, 1999, 40:854 -861.
  • 5Van De Wiele C, Versijpt J, Dierckx RA, et al. ^99Tc^m-HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma[J]. Nucl Med Commun, 2001, 22:269-275.
  • 6Dehdashti F, Mintun MA, Lewis JS, et al. In vivo assessment of tumor hypoxia in lung cancer with ^60Cu-ATSM [J]. Eur J Nucl Med Mol Imaging, 2003, 30:844 -850.
  • 7Kinuya S, Yokoyama K, Li XF, et al. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice : implications for pretherapeutic prediction of treatment outcomes with ^99Tc^m-sestamibi, 201 TL chloride and ^99Tc^m-HL91[J]. Eur J Nucl Med Mol Imaging, 2002, 29:1006 -1011.
  • 8Suzuki T, Nakamura K, Kawase T, et al. Monitoring of response to radiation therapy for human tumor xenografts using ^99Tc^m-HL91(4, 9-diaza-3, 3, 10, 10-tetramethyldodecan-2, 11 -dionedioxime[J]. Ann Nucl Med, 2003, 17:131 -138.
  • 9Dehdashti F, Grigsby PW, Mintun MA, et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with ^60Cu-ATSM: relationship to therapeutic response a preliminary report[J].Int J Radiat Oncol Biol Phys, 2003, 55 : 1233 - 1238.
  • 10Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance :Cu-ATSM-guided intensity-modulated radiation therapy [J].Int J Radial Oncol Biol Phys, 2001,49:1171 - 1182.

共引文献27

同被引文献22

  • 1唐劲天.肿瘤质子治疗技术研究进展[J].基础医学与临床,2005,25(2):97-101. 被引量:8
  • 2蔡伟明,李家敏.质子治疗肿瘤特点及国内外进展[J].中华放射肿瘤学杂志,2006,15(4):349-350. 被引量:5
  • 3丁小凡,陈龙华.重离子治疗肿瘤的进展[J].中华放射医学与防护杂志,2006,26(5):536-539. 被引量:5
  • 4于金明,陈少卿.生物靶区与生物适形放疗研究进展[J].中华肿瘤杂志,2006,28(11):801-803. 被引量:7
  • 5Joosten A, Bochud F, Moeckli R. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2- dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer[J]. Physics in Medicine Biology, 2014, 59(16): 4697-4722.
  • 6Sehippers M G, Bol G H, de Leeuw A A, et al. Position shifts and volume changes of pelvic and para-aortic nodes during IMRT for patients with cervical cancer[J]. Radiotherapy Oncology, 2014, 111(3): 442-445.
  • 7Morimoto M, Yoshioka Y, Konishi K, et al. Comparison of acute and subacute genitourinary and gastrointestinal adverse events ofradiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy[J]. Tumori, 2014, 100(3): 265-271.
  • 8Hakariya T, Obata S, Iqawa T, et al. Feasibility of simultaneous integrated boost IMRT (SIB-IMRT) for castration-resistant prostate cancer J]. Anticancer Research, 2014, 34(8): 4261-4265.
  • 9Vera E, Iorgulescu J B, Raper D M, et al. A review of stereotactic radiosurgery practice in the management of skull base meningiomas[J]. Journal of Neurological Surgery Part B Skull Base, 2014, 75(3): 152- 158.
  • 10Katayama S, Hantschke M, Lissner S, et al. Helical tomotherapy of the complete scalp and the ipsilateral lymph nodes in a case of scalp angiosarcoma[J]. Ent-ear Nose & Throat Journal, 2014, 93(6): e24-e28.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部